Clinical Trial Update: A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update shows weekly tirzepatide is being studied in adolescent participants with obesity or overweight and weight-related comorbidities; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 3 | Status: ACTIVE_NOT_RECRUITING